# Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension

> **NCT00380289** · NA · UNKNOWN · sponsor: **University of Cambridge** · enrollment: 66 (—)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Thiazide and beta blocker

## Key facts

- **NCT ID:** NCT00380289
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 66 (—)
- **Last updated:** 2006-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380289, "Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00380289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*